Skip to main content

Table 3 Association of dialysis circuit coagulation with patient and treatment characteristics

From: Avoidance of systemic anticoagulation during intermittent haemodialysis with heparin-grafted polyacrilonitrile membrane and citrate-enriched dialysate: a retrospective cohort study

 

No circuit coagulation (N = 255)

Circuit coagulation (N = 54)

OR (95% CI)1

P1

Age (years)

61.3 ± 16.0

61.3 ± 17.4

1.0 (0.98 – 1.02)

0.98

Male (N;%)

177 (69.4)

40 (74.1)

1.28 (0.58 – 2.83)

0.54

Vascular access (N;%)

    

  Permanent access

22 (8.6)

3 (5.6)

Ref

0.77

  Temporary catheter

233 (91.4)

51 (94.4)

1.72 (0.43 – 6.92)

 

Treatment number2

3 (1 – 6)

3 (2 – 7)

1.0 (0.94 – 1.09)

0.80

Ultrafiltration (ml/h)2

500 (250 – 625)

500 (333 – 625)

1.11 (0.97 – 1.28)3

0.13

Prescribed treatment time (min)

220 ± 46

222 ± 34

1.0 (0.99 – 1.01)

0.80

Effective blood flow (ml/min)

250 ± 39

231 ± 44

0.88 (0.80 – 0.96)3

0.006

APACHE II2

29 (22 – 37)

25 (20 – 33)

0.97 (0.94 – 1.01)

0.19

  1. 1Random effects logit model on panel data with patient identity as panel variable.
  2. 2Median with inter-quartile range.
  3. 3Per 100 ml increase.